We studied @ patients included at a single center in the TTM-trial , randomly assigned to TTM at @ C or @ C for @ h. Plasma samples were analyzed for inflammatory markers including interleukin ( IL ) IL-@ , IL-@ , IL-@ , IL-@ , tumor necrosis factor - ( TNF - ) , C-reactive protein ( CRP ) and procalcitonin ( PCT ) at randomization and @ , @ and @ h after CA .